Our findings suggest that GLP-1s could serve as an adjunctive therapy for HS patients, especially those with metabolic comorbidities, Neal Gupta, MD, a resident at SUNY Downstate Health Sciences University, told Healio
10.1128/JB.00271-08 Brenot A, King KY, Janowiak B, Griffith O, Caparon MG: Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes
The FDA has acknowledged reports linking Ozempic and other GLP-1 medications to delayed gastric emptying and ileus, but critics say the label still omits full warnings of the risks
Shaking can shear the peptide chains, rendering them inactive
Some appetite suppression may be noticeable within the first two to four weeks, but meaningful weight loss and metabolic improvements typically become more evident from weeks four to eight as the dose is gradually increased according to the trial protocol